The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.9M data for 1.2M Compounds and 9.3K Targets. Of those, 1,352K data for 627K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

9 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of Selective Small-Molecule Inhibitors for the฿-Catenin/T-Cell Factor Protein-Protein Interaction through the Optimization of the Acyl Hydrazone Moiety.EBI
University of Utah
Hot spot-based design of small-molecule inhibitors for protein-protein interactions.EBI
University of Utah
Direct targeting of฿-catenin: Inhibition of protein-protein interactions for the inactivation of Wnt signaling.EBI
Chemical Genomics Centre of The Max Planck Society
Small-Molecule Inhibitors Targeting the Canonical WNT Signaling Pathway for the Treatment of Cancer.EBI
Ocean University of China
Targeting the interaction of ?-catenin and TCF/LEF transcription factors to inhibit oncogenic Wnt signaling.EBI
Vu University Amsterdam
Biophysical Survey of Small-Molecule ?-Catenin Inhibitors: A Cautionary Tale.EBI
University of Southampton
Discovery of an Orally Bioavailable Small-Molecule Inhibitor for the ?-Catenin/B-Cell Lymphoma 9 Protein-Protein Interaction.EBI
H. Lee Moffitt Cancer Center and Research Institute
Optimization of Peptidomimetics as Selective Inhibitors for the ?-Catenin/T-Cell Factor Protein-Protein Interaction.EBI
H. Lee Moffitt Cancer Center and Research Institute